XML 41 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
DISCONTINUED OPERATIONS (Revenues and Net Income (Loss)) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Dec. 31, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Income (loss) from discontinued operations, net of taxes $ 1,182 $ (421) $ 9 $ (1,144)  
Genetic Assays and Platforms business          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Gain on sale of business/assets         $ 1,500
Genetic Assays and Platforms and Patient Testing          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Net sales     1,677 12,361  
Cost of goods sold     1,194 6,777  
Gross profit     483 5,584  
Selling, general and administrative expense     1,369 6,415  
Operating income (loss) from discontinued operations 219 (378) (954) (1,055)  
Gain on sale of business/assets 963 0 963 0  
Income (loss) from discontinued operations before income taxes     9 (1,055)  
Income tax expense     0 89  
Income (loss) from discontinued operations, net of taxes     9 (1,144)  
Discontinued operations | Genetic Assays and Platforms and Patient Testing          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Net sales 574 6,598      
Cost of goods sold 11 3,703      
Gross profit 563 2,895      
Selling, general and administrative expense 344 3,165      
Research and development expense 0 108 $ 68 $ 224  
Income (loss) from discontinued operations before income taxes 1,182 (378)      
Income tax expense 0 43      
Income (loss) from discontinued operations, net of taxes $ 1,182 $ (421)